PTC Therapeutics (PTCT) delivered earnings and revenue surprises of 9.74% and 13.41%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

PTC Inc (PTC) reports robust financial performance with a 25% increase in free cash flow and announces a $2 billion share repurchase authorization.

An enhanced premium tax credit for Marketplace plans will expire at 2025-end. If Congress doesn't act soon, millions may go uninsured, experts warn.

The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus ...

Q3 2024 Earnings Call Transcript November 7, 2024 PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.39, ...

The FDA is set to decide on four promising therapies in the next two weeks, including a CAR T for acute lymphoblastic ...

Good afternoon, ladies and gentlemen, and thank you for standing by, and welcome to today's PTC 2024 fourth quarter conference call. During this presen ...

PTC was expanded, or enhanced ... It's a "health care sharing alternative" that allows members to share in one another’s medical expenses. Consumers pay their own medical bills but get help ...

William Blair analyst Sami Corwin has maintained their bullish stance on PSTX stock, giving a Buy rating on November 8. Sami Corwin has given ...

Image-guided thermal ablation effective treatment option for patients with papillary thyroid cancer patients suggests a new study published in the JAMA.Image-guided thermal ablation has ...

PrivateThe Q2 earnings season has crossed the peak and is now nearing the end of the season. Out of 4699 companies listed on exchanges, 1852 companies have already declared their quarterly financials ...

US-headquartered PTC, a global software company, is looking to raise its average annual investment of $70 million in India to ...